Loading...
Loading...
BLFS| Name | Value |
|---|---|
| Revenues | 39.5M |
| Cost of Revenue | 27.7M |
| Gross Profit | 11.8M |
| Operating Expense | 28.0M |
| Operating I/L | -15.3M |
| Other Income/Expense | 6.4M |
| Interest Income | 0.4M |
| Pretax | -10.2M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -10.2M |
BioLife Solutions, Inc. develops and supplies bioproduction tools and services for the cell and gene therapy industry globally. Its proprietary biopreservation media products, including HypoThermosol FRS and CryoStor, mitigate preservation-induced cell damage. The ThawSTAR line offers automated vial and cryobag thawing products. Additionally, the company provides evo shipping containers, liquid nitrogen laboratory freezers, cryogenic equipment, and storage services for biologics and pharmaceuticals. BioLife markets and sells its products directly and through third-party distributors, catering to basic and applied research, as well as commercial manufacturing of biologic-based therapies.
